Recursion Pharmaceuticals, Inc. Class A RXRX 深 沪
已收盘 05-22 16:00:00 美东时间
3.01
-0.115
-3.68%
华盛通- 最 高3.52
- 今 开3.08
- 成交量 1374.88万股
- 最 低 2.77
- 昨 收 3.125
- 总市值 51.77万
- 52周最高 7.18
- 市盈率 静 --
- 换手率 7993.48%
- 52周最低 2.77
- 委 比 11.79%
- 总股本 0.00亿
- 历史最高 42.81
- 量 比 0.97
- 振 幅 24.00%
- 历史最低 1.10
- 每 手 1
- 风险率 0.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Citeline Announces Expanded Strategic Partnership With Recursion, Advancing AI-Enabled ClinTech Platform
Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ:RXRX), a leading tech-bio company decoding biology through advanced data
03-31 21:05
ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025
ARK's 2025 winners included Robinhood, AMD and Palantir, while its losers were The Trade Desk, Recursion and Twist.
02-25 04:52
Recursion Pharmaceuticals's Earnings Outlook
Recursion Pharmaceuticals (NASDAQ:RXRX) is set to give its latest quarterly ear...
02-25 03:02
Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby, CoreWeave, Salesforce, Lucid and more.
02-23 23:33
3 Small AI Plays to Buy for 2026
Wall Street ends 2026 positively with tech stocks dominating, but concerns over valuations drive interest in smaller AI stocks for 2026.
2025-12-27 02:28
Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10.
2025-12-18 02:06
Why Are Shares Of Recursion Pharmaceuticals Higher Today?
Shares of Recursion Pharmaceuticals are trading higher Monday after the company reported positive data from an ongoing trial.
2025-12-08 23:48
Jim Cramer: This Health Care Stock Has Been 'Horrendous'
Jim Cramer doesn't recommend Recursion Pharmaceuticals (NASDAQ: RXRX) due to weak earnings and CEO transition. Stock has mixed technicals and death cross.
2025-12-05 21:19
“生物科技大牛股猎手”Needham押宝这家“AI+新药研发”领军者 押注股价将狂飙68%
长期以来专注于挖掘生物科技大牛股的华尔街资管机构Needham近日发布研报称，维持该机构对于聚焦“AI+新药研发”的Recursion Pharmaceuticals, Inc.(RXRX.US)的“买入”这一最乐观看涨评级，目标价则维持在8美元——意味着Needham看好该公司股价接近翻倍，并表示Recursion Pharmaceuticals是“华尔街对冲基金们最为看好的12只纳斯达克便士股之一”。 来自Needham的资深分析师Gil Blum 基于多种因素重申对于Recursion Pharmaceuticals的看涨评级，指出该公司在AI技术全面驱动的药物研发领域处于非常强势的领先...
2025-09-16 12:10
美股异动 | 英伟达持仓概念股走低 CoreWeave(CRWV.US)跌超6%
周二，英伟达持仓概念股走低，截至发稿，NEBIUS(NBIS.US)、CoreWeave(CRWV.US)跌超6%，Recursion Pharmaceuti...
2025-08-19 23:59
